Sort
51,570 grants matching “autoimmune disease”
Understanding Risk Gradients from Environment on Native American Child Health Trajectories: Toxicants, Immunomodulation, Metabolic syndromes, & Metals Exposure
$4,242,490Johnnye L Lewis · University Of New Mexico Health Scis Ctr · UH3 · FY2020 · OD
Autoimmune Diseases Group
$4,236,810William T Barry · Rho Federal Systems Division, Inc. · UM2 · FY2020 · AI
Asthma and Allergic Diseases Group
$4,232,633Samuel Arbes · Rho Federal Systems Division, Inc. · UM2 · FY2019 · AI
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$4,226,384Rachel R. Caspi · National Eye Institute · ZIA · FY2023 · EY
Neuropathogenesis of Retroviral Infections
$4,223,061Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Discretionary Fund
$4,222,621Eugene W. St Clair · Duke University · U19 · FY2011 · AI
Oklahoma IDeA Network of Biomedical Research Excellence
$4,207,418Mark L Lang · University Of Oklahoma Hlth Sciences Ctr · P20 · FY2025 · GM
Clinical Research and Protocol Support Services
$4,193,882William O'Donnell · National Eye Institute · ZID · FY2009 · EY
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$4,190,009Rachel R. Caspi · National Eye Institute · ZIA · FY2024 · EY
Deciphering the molecular basis of T1D in human cells using functional genomics
$4,160,310Alexander Meissner · Harvard University · DP3 · FY2016 · DK
Humanized Mouse Avatars for T1D
$4,109,951Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · UC4 · FY2014 · DK
Studies of Inherited Causes of Fungal Susceptability
$4,100,812Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Defects in Immunoregulatory Cell Receptors in Patients with LeukemiaLymphoma
$4,070,979Thomas A Waldmann · Clinical Sciences · Z01 · FY2007 · CA
Asthma and Allergic Diseases Group
$4,049,541Samuel Arbes · Rho Federal Systems Division, Inc. · UM2 · FY2016 · AI
Oklahoma Shared Clinical and Translational Resources
$4,046,492Judith A James · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2018 · GM
Placental Microvasculature, Environmental Influences and Fetal Growth Restriction
$4,045,846Anthony O Odibo · University Of South Florida · U01 · FY2015 · HD
Systematic identification of functional T1D-associated non-coding SNPs using genetic, transcriptomic and epigenetic methods
$4,026,008Stephen S. Rich · University Of Virginia · DP3 · FY2016 · DK
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
$4,005,841Stacey Lynn Clardy · University Of Utah · U01 · FY2021 · NS
Program in Clinical Research, Clinical Support Services and Clinical Training
$4,004,212Stavros Garantziotis · National Institute Of Environmental Health Sciences · ZID · FY2018 · ES
Data Management and Portal for the INCLUDE (DAPI) Project
$4,002,500Adam Cain Resnick · Children'S Hosp Of Philadelphia · U2C · FY2020 · HL
CENTER FOR COMPUTATIONAL BIOLOGY (CCB)(RMI)
$4,001,657Arthur W Toga · University Of California Los Angeles · U54 · FY2009 · RR
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
$4,000,000Christina Millin · Rho Federal Systems Division, Inc. · N01 · FY2022 · AI
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
$4,000,000Christina Millin · Rho Federal Systems Division, Inc. · N01 · FY2023 · AI
Oklahoma Shared Clinical and Translational Resources
$3,999,999Judith A James · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2024 · GM
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
$3,970,523Stacey Lynn Clardy · University Of Utah · U01 · FY2022 · NS